Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15

Immunity

Volumn 26, Issue 4, 2007, Pages 503-517

  Lucas, Mathias ^a,b   Schachterle, William ^a   Oberle, Karin ^b   Aichele, Peter ^b   Diefenbach, Andreas ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CELLIMMUNO

Indexed keywords

GLYCOPROTEIN P 15095; INTERFERON; INTERLEUKIN 15;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CELL INTERACTION; CONTROLLED STUDY; DENDRITIC CELL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; IMMUNOLOGICAL PROCEDURES; IMMUNOSTIMULATION; IN VIVO STUDY; LOCAL LYMPH NODE ASSAY; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS VIRULENCE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11C; CROSS-PRIMING; DENDRITIC CELLS; INTERFERON TYPE I; INTERLEUKIN-15; KILLER CELLS, NATURAL; LISTERIA INFECTIONS; LYMPH NODES; MACROPHAGES; MICE; MICE, INBRED STRAINS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 34247100277     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.03.006     Document Type: Article

References (61)

1. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., and Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 (1998) 143-150
2. Andoniou C.E., van Dommelen S.L., Voigt V., Andrews D.M., Brizard G., Asselin-Paturel C., Delale T., Stacey K.J., Trinchieri G., and Degli-Esposti M.A. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6 (2005) 1011-1019
3. Andrews D.M., Scalzo A.A., Yokoyama W.M., Smyth M.J., and Degli-Esposti M.A. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4 (2003) 175-181
4. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25 (2006) 331-342
5. Bajenoff M., Breart B., Huang A.Y., Qi H., Cazareth J., Braud V.M., Germain R.N., and Glaichenhaus N. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203 (2006) 619-631
6. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
7. Baratin M., Roetynck S., Lepolard C., Falk C., Sawadogo S., Uematsu S., Akira S., Ryffel B., Tiraby J.G., Alexopoulou L., et al. Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 102 (2005) 14747-14752
8. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107 (2006) 159-166
9. Chambers B.J., Salcedo M., and Ljunggren H.G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5 (1996) 311-317
10. Chen S., Kawashima H., Lowe J.B., Lanier L.L., and Fukuda M. Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J. Exp. Med. 202 (2005) 1679-1689
11. Cooper M.A., Bush J.E., Fehniger T.A., VanDeusen J.B., Waite R.E., Liu Y., Aguila H.L., and Caligiuri M.A. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100 (2002) 3633-3638
12. Cudkowicz G., and Yung Y.P. Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the anti-macrophage agent seakem carrageenan. J. Immunol. 119 (1977) 483-487
13. Dalod M., Hamilton T., Salomon R., Salazar-Mather T.P., Henry S.C., Hamilton J.D., and Biron C.A. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 197 (2003) 885-898
14. Djeu J.Y., Heinbaugh J.A., Holden H.T., and Herberman R.B. Role of macrophages in the augmentation of mouse natural killer cell activity by poly I:C and interferon. J. Immunol. 122 (1979) 182-188
15. Dubois S., Mariner J., Waldmann T.A., and Tagaya Y. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 17 (2002) 537-547
16. Dunn P.L., and North R.J. Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect. Immun. 59 (1991) 2892-2900
17. + T cells. J. Exp. Med. 193 (2001) 219-231
18. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., Bougras G., Muller W.A., Moretta L., and Munz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101 (2004) 16606-16611
19. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., Perricaudet M., Tursz T., Maraskovsky E., and Zitvogel L. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5 (1999) 405-411
20. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., and Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105 (2005) 4416-4423
21. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., and Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195 (2002) 327-333
22. Gidlund M., Orn A., Wigzell H., Senik A., and Gresser I. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273 (1978) 759-761
23. Hart O.M., Athie-Morales V., O'Connor G.M., and Gardiner C.M. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J. Immunol. 175 (2005) 1636-1642
24. Herberman R.B., Nunn M.E., and Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16 (1975) 216-229
25. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., and Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17 (2002) 19-29
26. Jinushi M., Takehara T., Kanto T., Tatsumi T., Groh V., Spies T., Miyagi T., Suzuki T., Sasaki Y., and Hayashi N. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Immunol. 170 (2003) 1249-1256
27. Jinushi M., Takehara T., Tatsumi T., Kanto T., Groh V., Spies T., Suzuki T., Miyagi T., and Hayashi N. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J. Immunol. 171 (2003) 5423-5429
28. + T cells by exogenous cell-associated antigens. Immunity 17 (2002) 211-220
29. Karre K., Ljunggren H.G., Piontek G., and Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319 (1986) 675-678
30. Kassim S.H., Rajasagi N.K., Zhao X., Chervenak R., and Jennings S.R. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J. Virol. 80 (2006) 3985-3993
31. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C.R., et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191 (2000) 771-780
32. Kiessling R., Klein E., and Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5 (1975) 112-117
33. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., French A.R., Sunwoo J.B., Lemieux S., Hansen T.H., and Yokoyama W.M. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436 (2005) 709-713
34. Koka R., Burkett P., Chien M., Chai S., Boone D.L., and Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J. Immunol. 173 (2004) 3594-3598
35. Koschella M., Voehringer D., and Pircher H. CD40 ligation in vivo induces bystander proliferation of memory phenotype CD8 T cells. J. Immunol. 172 (2004) 4804-4811
36. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., Orihuela M.M., Akira S., Yokoyama W.M., and Colonna M. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 (2004) 107-119
37. Lodolce J.P., Burkett P.R., Boone D.L., Chien M., and Ma A. T cell-independent interleukin 15Ralpha signals are required for bystander proliferation. J. Exp. Med. 194 (2001) 1187-1194
38. Magram J., Connaughton S.E., Warrier R.R., Carvajal D.M., Wu C.Y., Ferrante J., Stewart C., Sarmiento U., Faherty D.A., and Gately M.K. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4 (1996) 471-481
39. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., and Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5 (2004) 1260-1265
40. Masopust D., Vezys V., Marzo A.L., and Lefrançois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291 (2001) 2413-2417
41. Mattei F., Schiavoni G., Belardelli F., and Tough D.F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167 (2001) 1179-1187
42. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
43. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2 (2002) 957-964
44. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., and Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 264 (1994) 1918-1921
45. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., Caligiuri M.A., Durbin J.E., and Biron C.A. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169 (2002) 4279-4287
46. O'Leary J.G., Goodarzi M., Drayton D.L., and von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7 (2006) 507-516
47. Ohteki T., Tada H., Ishida K., Sato T., Maki C., Yamada T., Hamuro J., and Koyasu S. Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J. Exp. Med. 203 (2006) 2329-2338
48. Pessino A., Sivori S., Bottino C., Malaspina A., Morelli L., Moretta L., Biassoni R., and Moretta A. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188 (1998) 953-960
49. Prlic M., Blazar B.R., Farrar M.A., and Jameson S.C. In vivo survival and homeostatic proliferation of natural killer cells. J. Exp. Med. 197 (2003) 967-976
50. Probst H.C., Tschannen K., Odermatt B., Schwendener R., Zinkernagel R.M., and Van Den Broek M. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin. Exp. Immunol. 141 (2005) 398-404
51. Reinhardt R.L., Khoruts A., Merica R., Zell T., and Jenkins M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410 (2001) 101-105
52. Schmidt K.N., Leung B., Kwong M., Zarember K.A., Satyal S., Navas T.A., Wang F., and Godowski P.J. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J. Immunol. 172 (2004) 138-143
53. Shinozaki M., Hirahashi J., Lebedeva T., Liew F.Y., Salant D.J., Maron R., and Kelley V.R. IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J. Clin. Invest. 109 (2002) 951-960
54. Sivori S., Falco M., Della Chiesa M., Carlomagno S., Vitale M., Moretta L., and Moretta A. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. USA 101 (2004) 10116-10121
55. Tough D.F., Borrow P., and Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272 (1996) 1947-1949
56. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47 (1989) 187-376
57. Tripp C.S., Wolf S.F., and Unanue E.R. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90 (1993) 3725-3729
58. Waldmann T.A., Dubois S., and Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14 (2001) 105-110
59. Welsh Jr. R.M. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 148 (1978) 163-181
60. Zammit D.J., Cauley L.S., Pham Q.M., and Lefrancois L. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 22 (2005) 561-570
61. + T cells in vivo by IL-15. Immunity 8 (1998) 591-599